|
|
Additional
Resources
|
|
What Is Reactive Arthritis
By Trevor Vernon
What is Reactive arthritis and how can it be effectively dealt with.Reactive arthritis was first described by a German military physician called Hans Reiter in 1916. He described the Read more...
|
|
|
|
Arthritis
Anaprox Medicine - Uses, Dosage And Side Effects
By alien
Naproxen is in a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by reducing hormones that may cause inflammation and pain in the body. Naproxen is also effective in treating other mild to moderate pain, such as menstrual pain, headache, toothache, and temporarily reduces fever.
Anaprox Dosage
Take the forgotten dose as soon as you remember. If it is almost time for your next dose, skip the one you missed and go back to your regular schedule. Never take 2 doses at the same time. For the treatment of Mild to Moderate Pain, Menstrual Cramps, the usual starting dose is 550 milligrams every 12 hours.
For the treatment of Rheumatoid Arthritis, Osteoarthritis, and Ankylosing Spondylitis, the usual starting dose is 275 milligrams or 550 milligrams 2 times a day.
Uses of Anaprox
Naproxen is used to reduce pain, inflammation, and stiffness that may be caused by many conditions, such as osteoarthritis, rheumatoid arthritis, injury, abdominal cramps associated with menstruation. This medication is also used to treat mild to moderate pain such as headaches, menstrual pain, toothaches, and sometimes used for fevers.
Side Effects of Anaprox
Before taken Anaprox medicine, you should discuss the side effects with your doctor. If any develop or change in intensity, then you should inform your doctor as soon as possible. This drug should be used with caution if you have kidney or liver disease. It can cause liver inflammation in some people. Side effects may cause abdominal pain, constipation, drowsiness, headache, rash-like
symptoms.
Warnings and precautions before taking Anaprox:
* Anaprox is not usually given to children under 12 years old. Ask your doctor as your specific case may be different. Children taking this drug may require special instructions. Be sure to ask about these differences if you are getting this medication for your child.
* If you have heart disease or high blood pressure, then drug can increase water retention. It also may cause vision problems. So you should be used this medicine with extra caution. After taken this medicine, then you may feel dizzy, or drowsiness. So you should not participate in any activities that require alertness such as driving and operate machinery.
Drug Interaction :-
If you are taking Anaprox with certain other drugs, then the effects of either could be increased, decreased, or altered. So it is especially important to check with your doctor before combining Anaprox with the following:
* ACE inhibitors such as the blood pressure medication Capoten
* Beta blockers, including blood pressure drugs such as Inderal
* Certain water pills such as Lasix
* Furosemide
* Lithium
* Methotrexate
* Naproxen in other forms, such as Naprosyn
* Oral diabetes drugs such as Micronase
* Probenecid
* Warfarin
Overdose
Symptoms of overdose may include:
* dizziness
* extreme tiredness
* confusion
* drowsiness
* stomach pain
* heartburn
* upset stomach
* vomiting
* slow or difficult breathing
* decreased urination Alien writes for prescription drugs. He also writes for cymbalta and stress symptoms .
We strive to provide only quality information, so
if
there is a specific topic related to arthritis
that you would
like us to cover, please contact us at any time.
And again, thank you to those contributing daily to
our Arthritis
Website, especially
regarding "osteoarthritis obesity".
Discounted
Arthritis Online Auction
If you can't find the
Arthritis information you are looking for please
try our Google
Search
Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: Biological: adalimumab (Humira)<br/><b>Sponsor</b>: Abbott<br/><b>Active, not recruiting</b> - verified February 2010
A Study on the Prevalence of the Anti-MCV Anti-body in an Irish Rheumatoid Arthritis (RA) Population and the Impact of Biomarker Status on the Management of Irish Patients With Early RA
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: Other: This is a non-drug study. No treatment is mandated by the protocol. Routine blood draws (as per normal clinical care) will be taken through the study.<br/><b>Sponsors</b>: Abbott; Clinical Trial End-Point (CTEP) Ltd; JSS Medical Research Inc.<br/><b>Not yet recruiting</b> - verified March 2010
Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA)
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Abbott; Institute of Political Economical & Social Researches, Greece<br/><b>Active, not recruiting</b> - verified February 2010
Effectiveness of Adalimumab on Extraarticular Manifestation in Patients With Active Rheumatoid Arthritis
<b>Conditions</b>: Active Rheumatoid Arthritis; Osteoporoses<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Abbott; Centre of Biostatistics and Analyses, Faculty of Medicine, Masaryk University Brno, Czech Republic<br/><b>Recruiting</b> - verified February 2010
The Relation Between Dedicated Extremity MRI Synovitis and Structural Deterioration Radiographic in Patients With Rheumatoid Arthritis in Clinical Remission. Preliminary Study
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: Other: MRI<br/><b>Sponsor</b>: Centre Hospitalier Universitaire de Nice<br/><b>Not yet recruiting</b> - verified January 2010
Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Interventions</b>: Dietary Supplement: Oncoxin + Viusid; Dietary Supplement: Placebo<br/><b>Sponsor</b>: Catalysis SL<br/><b>Recruiting</b> - verified November 2009
Monitoring Epstein-Barr Virus (EBV) Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive Drugs
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: Biological: Venous blood sample<br/><b>Sponsor</b>: Assistance Publique Hopitaux De Marseille<br/><b>Recruiting</b> - verified October 2009
A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Interventions</b>: Drug: PF-04171327 10 mg; Other: Prednisone Placebo; Drug: PF-04171327 25 mg; Other: Prednisone Placebo; Drug: Prednisone 5 mg; Other: Placebo for PF-04171327; Other: Placebo; Other: Placebo for PF-04171327<br/><b>Sponsor</b>: Pfizer<br/><b>Recruiting</b> - verified March 2010
Targeting Synovitis in Early Rheumatoid Arthritis
<b>Conditions</b>: Rheumatoid Arthritis; Polyarthritis<br/><b>Interventions</b>: Other: Musculoskeletal Ultrasound; Other: 28 Joint Disease Activity Score<br/><b>Sponsors</b>: NHS Greater Glasgow and Clyde; University of Glasgow; Chief Scientist Office of the Scottish Government; Wyeth; Translational Medicine Research Collaboration<br/><b>Recruiting</b> - verified September 2009
Living Well With Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Interventions</b>: Behavioral: Self-Help Group; Other: Education (Control) Group<br/><b>Sponsors</b>: Brigham and Women's Hospital; Bristol-Myers Squibb<br/><b>Recruiting</b> - verified September 2009
A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Imperial College London; Merck<br/><b>Recruiting</b> - verified February 2010
Ultrasonography as a Biomarker in Early Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Imperial College London; Medical Research Council<br/><b>Recruiting</b> - verified February 2010
Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients
<b>Condition</b>: Active Rheumatoid Arthritis<br/><b>Intervention</b>: Drug: Etanercept<br/><b>Sponsor</b>: Wyeth<br/><b>Recruiting</b> - verified July 2009
A Study Comparing CRx-102 Plus Disease-Modifying Anti-Rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Interventions</b>: Other: CRx-102 plus DMARD therapy; Other: Placebo plus DMARD therapy<br/><b>Sponsor</b>: CombinatoRx<br/><b>Completed</b> - verified September 2008
Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA)
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Interventions</b>: Drug: Tranilast; Drug: Placebo comparator<br/><b>Sponsors</b>: Imperial College London; Nuon Therapeutics, Inc.<br/><b>Withdrawn</b> - verified July 2009
RESTART C0168Z05 Rheumatoid Arthritis Study
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: Biological: Infliximab<br/><b>Sponsors</b>: Centocor Ortho Biotech Services, L.L.C.; Schering-Plough<br/><b>Active, not recruiting</b> - verified January 2010
Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?
<b>Conditions</b>: Rheumatoid Arthritis; Arthritis; Joint Diseases<br/><b>Intervention</b>: Drug: Adalimumab (Humira)<br/><b>Sponsors</b>: Hvidovre University Hospital; Abbott<br/><b>Completed</b> - verified June 2008
Rosuvastatin in Rheumatoid Arthritis (RORA)
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Interventions</b>: Drug: rosuvastatin; Drug: placebo<br/><b>Sponsor</b>: University of Dundee<br/><b>Completed</b> - verified May 2008
Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Interventions</b>: Drug: Certolizumab pegol; Other: Placebo<br/><b>Sponsor</b>: UCB, Inc.<br/><b>Recruiting</b> - verified February 2010
Study Evaluating Single Doses of SBI-087 in Subjects With Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: Drug: SBI-087<br/><b>Sponsors</b>: Wyeth; Trubion Pharmaceuticals<br/><b>Active, not recruiting</b> - verified July 2009
|
|
